Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Scholar Rock Holding Corp | Director | Common Stock | 13.5K | $121K | $8.99 | Jun 27, 2024 | Direct |
VOLITIONRX LTD | Director | Common Stock | 27.9K | $23.2K | $0.83 | Jan 12, 2023 | Direct |
Prime Medicine, Inc. | Chief Business Officer | Stock Option (right to buy) | 38.6K | May 17, 2024 | Direct | ||
Scholar Rock Holding Corp | Director | Stock Option (Right to Buy) | 18K | Jun 27, 2024 | Direct | ||
Codiak BioSciences, Inc. | Officer title: Chief Business Officer and Head of Corporate Strategy | Restricted Stock Units | 16.3K | Feb 16, 2022 | Direct | ||
Codiak BioSciences, Inc. | Officer title: Chief Business Officer and Head of Corporate Strategy | Stock Option (Right to Buy) | 10.9K | Feb 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SRRK | Scholar Rock Holding Corp | Jun 27, 2024 | 2 | $0 | 4 | Jul 1, 2024 | Director |
PRME | Prime Medicine, Inc. | May 17, 2024 | 1 | $0 | 4 | May 21, 2024 | Chief Business Officer |
PRME | Prime Medicine, Inc. | Feb 21, 2024 | 1 | $0 | 4 | Feb 23, 2024 | Chief Business Officer |
SRRK | Scholar Rock Holding Corp | Apr 6, 2023 | 1 | $0 | 4 | Apr 10, 2023 | Director |
SRRK | Scholar Rock Holding Corp | Apr 6, 2023 | 0 | $0 | 3 | Apr 10, 2023 | Director |
PRME | Prime Medicine, Inc. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Business Officer |
VNRX | VOLITIONRX LTD | Jan 12, 2023 | 1 | $0 | 4 | Jan 13, 2023 | Director |
PRME | Prime Medicine, Inc. | Oct 19, 2022 | 0 | $0 | 3 | Oct 19, 2022 | Chief Business Officer |
VNRX | VOLITIONRX LTD | Oct 13, 2022 | 1 | $0 | 4 | Oct 14, 2022 | Director |
VNRX | VOLITIONRX LTD | Jun 23, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
VNRX | VOLITIONRX LTD | Apr 7, 2022 | 2 | $0 | 4 | Apr 8, 2022 | Director |
CDAKQ | Codiak BioSciences, Inc. | Feb 16, 2022 | 2 | $0 | 4 | Feb 18, 2022 | Officer title: Chief Business Officer and Head of Corporate Strategy |
CDAKQ | Codiak BioSciences, Inc. | Jan 19, 2022 | 2 | $0 | 4 | Jan 21, 2022 | Officer title: Chief Business Officer and Head of Corporate Strategy |